Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.

Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM.

Nat Commun. 2019 Apr 23;10(1):1906. doi: 10.1038/s41467-019-09930-3.

2.

Challenges in the Integration of Omics and Non-Omics Data.

López de Maturana E, Alonso L, Alarcón P, Martín-Antoniano IA, Pineda S, Piorno L, Calle ML, Malats N.

Genes (Basel). 2019 Mar 20;10(3). pii: E238. doi: 10.3390/genes10030238. Review.

3.

Determining Significance in the New Era for P Values.

Pineda S, Sirota M.

J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):547-548. doi: 10.1097/MPG.0000000000002120. No abstract available.

PMID:
30052572
4.

Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.

Pineda S, Sigdel TK, Chen J, Jackson AM, Sirota M, Sarwal MM.

Front Immunol. 2018 Jan 31;9:107. doi: 10.3389/fimmu.2018.00107. eCollection 2018.

5.

Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant.

Pineda S, Sigdel TK, Chen J, Jackson AM, Sirota M, Sarwal MM.

Front Immunol. 2017 Dec 5;8:1687. doi: 10.3389/fimmu.2017.01687. eCollection 2017. Erratum in: Front Immunol. 2018 Jan 31;9:107.

6.

Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer.

Pineda S, Van Steen K, Malats N.

Genet Epidemiol. 2017 Sep;41(6):567-573. doi: 10.1002/gepi.22053. Epub 2017 Jun 23.

PMID:
28643332
7.

Toward the integration of Omics data in epidemiological studies: still a "long and winding road".

López de Maturana E, Pineda S, Brand A, Van Steen K, Malats N.

Genet Epidemiol. 2016 Nov;40(7):558-569. doi: 10.1002/gepi.21992. Epub 2016 Jul 18.

PMID:
27432111
8.

Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer.

Pineda S, Real FX, Kogevinas M, Carrato A, Chanock SJ, Malats N, Van Steen K.

PLoS Genet. 2015 Dec 8;11(12):e1005689. doi: 10.1371/journal.pgen.1005689. eCollection 2015 Dec.

9.

Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases.

Pineda S, Gomez-Rubio P, Picornell A, Bessonov K, Márquez M, Kogevinas M, Real FX, Van Steen K, Malats N.

Hum Hered. 2015;79(3-4):124-36. doi: 10.1159/000381184. Epub 2015 Jul 28.

10.

Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.

Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, García-Closas M, Lloreta J, Baum E, González-Neira A, Carrato A, Navarro A, Silverman DT, Real FX, Malats N.

PLoS One. 2014 May 12;9(5):e89952. doi: 10.1371/journal.pone.0089952. eCollection 2014.

11.

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Lundgren K, Brown M, Pineda S, Cuzick J, Salter J, Zabaglo L, Howell A, Dowsett M, Landberg G; TransATAC investigators.

Breast Cancer Res. 2012 Apr 4;14(2):R57.

12.

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF.

J Clin Oncol. 2011 Nov 10;29(32):4273-8. doi: 10.1200/JCO.2010.31.2835. Epub 2011 Oct 11.

PMID:
21990413
13.

Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007.

Pezzoli L, Pineda S, Halkyer P, Crespo G, Andrews N, Ronveaux O.

Trop Med Int Health. 2009 Mar;14(3):355-61. doi: 10.1111/j.1365-3156.2009.02231.x. Epub 2009 Jan 28.

Supplemental Content

Loading ...
Support Center